Publications 2021

Sveen KA, Holte KB, Svanteson M, Hanssen KF, Nilsson J, Bengtsson E, Berg TJ (2021)
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
Diabetes Care, 44 (6), 1402-1409
DOI 10.2337/dc20-2089

Sveen KA, Smith G, Bjorkbacka H, Orho-Melander M, Engstrom G, Goncalves I, Melander O, Nilsson J, Bengtsson E (2021)
High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women
J. Intern. Med.
DOI 10.1111/joim.13393

Publications 2020

Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
PLoS One, 15 (5), e0233174
DOI 10.1371/journal.pone.0233174

Publications 2015

Sveen KA, Dahl-Jorgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2015)
Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
J. Diabetes Complications, 29 (3), 407-412
DOI 10.1016/j.jdiacomp.2014.12.011

Publications 2014

Sveen KA, Nerdrum T, Hanssen KF, Brekke M, Torjesen PA, Strauch CM, Sell DR, Monnier VM, Dahl-Jorgensen K, Steine K (2014)
Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: Associations with protein glycation
Diabetes Vasc. Dis. Res., 11 (2), 84-91
DOI 10.1177/1479164113518805

Publications 2013

Sveen KA, Karime B, Jorum E, Mellgren SI, Fagerland MW, Monnier VM, Dahl-Jorgensen K, Hanssen KF (2013)
Small- and Large-Fiber Neuropathy After 40 Years of Type 1 Diabetes Associations with glycemic control and advanced protein glycation: the Oslo Study
Diabetes Care, 36 (11), 3712-3717
DOI 10.2337/dc13-0788

Publications 2012

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes A 24-month, double-blind, randomized, placebo-controlled trial
Diabetes Care, 35 (5), 1095-1097
DOI 10.2337/dc11-1895

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
Diabetes Care, 35 (11), E80
DOI 10.2337/dc12-1124